Cholesterol-containing plasma membrane of antigen-presenting cell

The cholesterol-containing plasma membrane of antigen-presenting cells (APCs), such as macrophages and dendritic cells, is a critical structural and functional entity in the immune system. It is characterized by the presence of lipid rafts—microdomains enriched in cholesterol and sphingolipids that serve as platforms for the assembly of signaling molecules, including Major Histocompatibility Complex class II (MHC II) and various co-stimulatory receptors (Source: Hiltbold et al., 2003, Journal of Immunology). These rafts are essential for the efficient processing and presentation of antigens to T cells, thereby initiating adaptive immune responses. Pharmacologically, this target is significant because agents like Amphotericin B and saponin-based adjuvants (e.g., QS-21) interact with membrane cholesterol to modulate immune activity, often by promoting the secretion of pro-inflammatory cytokines or facilitating antigen entry into the cytosol (Source: Mesa-Arango et al., 2012, Frontiers in Microbiology). Conversely, certain intracellular pathogens like Leishmania donovani evade the immune system by depleting host membrane cholesterol, which disrupts lipid raft integrity and impairs antigen presentation (Source: Sen et al., 2011, Journal of Biological Chemistry). Consequently, the cholesterol content and organization of APC membranes represent a unique therapeutic target for vaccine development, anti-infective strategies, and the management of inflammatory diseases.

Other names

Lipid rafts of antigen-presenting cellsCholesterol-rich microdomains of APCsAntigen-presenting cell plasma membrane cholesterolAPC membrane cholesterol

The primary mechanisms include: 1. Direct binding and sequestration of membrane cholesterol, leading to the disruption of lipid raft-associated signaling complexes (Source: Mesa-Arango et al., 2012). 2. Modulation of Major Histocompatibility Complex class II (MHC II) clustering and antigen presentation efficiency (Source: Hiltbold et al., 2003). 3. Activation of pro-inflammatory pathways through the recruitment of TLR-associated adapter proteins following membrane perturbation (Source: Sau et al., 2003). 4. Facilitation of endosomal escape for antigens in the context of vaccine adjuvanticity (Source: Den Brok et al., 2016).